908 Devices Inc. (NASDAQ:MASS) Q3 2024 Earnings Call Transcript November 12, 2024 908 Devices Inc. misses on earnings ...

Fintel reports that on November 13, 2024, Leerink Partners downgraded their outlook for 908 Devices (NasdaqGM:MASS) from ...

A public company with ties to the Triangle is shifting some of its operations from Massachusetts to Morrisville.

Devices Inc. ( (MASS) ) has released its Q3 earnings. Here is a breakdown of the information 908 Devices Inc. presented to its investors.

Leerink downgraded 908 Devices (MASS) to Market Perform from Outperform with a price target of $4, down from $12. Though the firm still sees ...

BOSS Wallet数据来源，ChainLink最新价格消息，LINK实时价格下跌-2.09%至$12.908，交易量$8.23亿从k线图的解析中看出，现在属于震荡趋势。相比11:00较大幅上涨，比05:00有所下降。交易量上升，价格下跌，卖压显著 ...

Based on the one-year price targets offered by 3 analysts, the average target price for 908 Devices Inc (NASDAQ:MASS) is $14 ...

This was for a 908-gram White Alba Truffle at HK$ 1.2 million. All for a good cause, proceeds from this auction will be ...

908 Devices Inc. (NASDAQ: MASS)是手持式和台式质谱设备的先驱，报告2024年第三季度收入增长17%，达到1680万美元，高于去年同期的1430万美元。 尽管收入有所增长，但公司面临一些不利因素，包括联邦预算批准和国际合同的延迟，导致收入低于预期。因此，908 Devices将2024年收入指引下调至5600万-5800万美元，增长率为11%-15%。 要点 908 D ...

周三，Leerink Partners调整了对908 Devices Inc. (NASDAQ: MASS)的立场，将其股票评级从"跑赢大市"下调至"市场表现"，并将目标价从$12大幅下调至$4。 这一决定是由于公司面临的市场挑战日益增加，特别是在生物制药和生命科学板块，而这些挑战又因法医市场前景不确定而加剧。法医市场约占公司收入的80%。 该公司列举了几个降级的原因，包括生物制药/生命科学领域持 ...

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the third quarter ...

证券之星消息，截至2024年11月13日收盘，芭田股份(002170)报收于8.2元，下跌0.97%，换手率2.81%，成交量20.0万手，成交额1.63亿元。